FdaApplication
NDA 216264
Identifiers
- fda_app_no: NDA216264
Properties
| Property | Value |
|---|---|
| applicant_name | PROVEPHARM SAS |
| application_type | NDA |
| approval_date | 2022-07-08 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| BLUDIGO | INDIGOTINDISULFONATE SODIUM | 40MG/5ML (8MG/ML) | SOLUTION;INTRAVENOUS |
1 product